NASDAQ:UTHR - United Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$127.09 +0.05 (+0.04 %)
(As of 10/17/2018 04:00 PM ET)
Previous Close$127.04
Today's Range$126.18 - $128.50
52-Week Range$100.57 - $152.55
Volume11,584 shs
Average Volume378,215 shs
Market Capitalization$5.57 billion
P/E Ratio11.70
Dividend YieldN/A

Analyst Ratings

United Therapeutics (NASDAQ:UTHR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for United Therapeutics in the last 12 months. Their average twelve-month price target is $140.8333, suggesting that the stock has a possible upside of 10.81%. The high price target for UTHR is $253.00 and the low price target for UTHR is $95.00. There are currently 2 sell ratings, 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score:
Ratings Breakdown: 2 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $140.8333$140.8333$139.6667$133.3750
Price Target Upside: 10.81% upside18.47% upside13.01% upside24.16% upside

United Therapeutics (NASDAQ:UTHR) Consensus Price Target History

Price Target History for United Therapeutics (NASDAQ:UTHR)

United Therapeutics (NASDAQ:UTHR) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/12/2018Standpoint ResearchUpgradeHold ➝ BuyLowView Rating Details
9/27/2018WedbushSet Price TargetBuy$253.00HighView Rating Details
8/13/2018HC WainwrightSet Price TargetHold$95.00MediumView Rating Details
8/8/2018Credit Suisse GroupDowngradeNeutral ➝ UnderperformLowView Rating Details
8/2/2018CowenReiterated RatingHold$110.00MediumView Rating Details
8/2/2018BarclaysReiterated RatingSell$100.00HighView Rating Details
1/5/2018OppenheimerBoost Price TargetOutperform$180.00LowView Rating Details
7/14/2017Jefferies Financial GroupReiterated RatingSell$105.00LowView Rating Details
7/6/2017UBS GroupReiterated RatingSell$106.00LowView Rating Details
4/11/2017JPMorgan Chase & Co.Set Price TargetHold$125.00LowView Rating Details
2/23/2017LADENBURG THALM/SH SHDowngradeBuy ➝ Neutral$145.00N/AView Rating Details
2/23/2017Leerink SwannBoost Price TargetMarket Perform$127.00 ➝ $148.00N/AView Rating Details
(Data available from 10/17/2016 forward)
This page was last updated on 10/17/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel